Study objectives: To investigate whether total sleep deprivation (TSD) affects circulating concentrations of neuron-specific enolase (NSE) and S100 calcium binding protein B ( 
Introduction
With increasing duration of wakefulness, there is an increase in cerebrospinal fluid (CSF) concentrations of - [1] [2] [3] . In contrast, decrease during sleep, i.e. a period during which the brain is minimally sensitive to environmental factors. As the prod peptides in the brain is intimately linked to neuronal activity 4, 5 , these findings suggest that nocturnal sleep may function as an offline period (i. peptide accumulation. The aggregation of these peptides is hypothesized to be linked to neurodegenerative processes, most notably in Alzheimer's disease 6 .
Neuronal damage has also been found to be indicated by elevations of two other neurochemical markers: neuron-specific enolase (NSE) -an enzyme found in all neurons 7 -and S100 calcium binding protein B (S-100B) -a protein which is mainly found in the glial cells of the peripheral and central nervous system 8 . However, as of yet, evidence to support that an acute disruption of the sleep-wake cycle affects circulating concentrations of these markers of neuronal damage in healthy young men is lacking. Thus, in the present study, we assessed circulating concentrations of peptides 1-42 and 1-40, NSE, and S-100B in 15 healthy young men, both before and after a night of either normal-duration sleep or total sleep deprivation.
Materials and Methods
Participants. Fifteen healthy Caucasian male subjects, all non-smokers, participated in the study.
Participants were 23.3 ± 0.9 years old and had a mean body mass index of 23.4 ± 0.6 kg/m2.
Exclusion criteria were as follows: night shift work or a transmeridian travel in the previous three months, a reported current or history of physical or psychiatric disorders, or if subjects were currently taking medication for any such condition. An interview prior to the experiment 4 ensured that all subjects enrolled in the study reported to have a normal sleep-wake rhythm, i.e. NJ, USA). Collected blood was allowed to clot for 30 minutes, followed by centrifugation at 2000 RPMs and 4° C for 10 minutes. Following its separation, ~1.5 ml serum and ~1.5 ml plasma for each subject were immediately frozen and stored until analysis at -80° C. Serum levels of NSE and S-100B (required serum volume: 500 µl) were measured using the Modular system (Cobas E601) and NSE and S-100B reagent kits (Roche Diagnostics, Basel, Switzerland).
One subject from an initial sample of 16 subjects was excluded from analysis in the present study as his serum concentrations of NSE/S-100B after sleep loss were ~4 standard deviations higher than respective mean concentrations.
-40 and 1-42
(required plasma volume: 500 µl) were assessed simultaneously using a highly sensitive Luminex xMAP® based method (INNOeach individual were analyzed on the same plate. Concentrations were determined using standard measurements were performed on a Luminex®200 analyzer (Luminex Corporation, Austin, TX, USA was considered significant. .
Results

Acute sleep loss increases morning serum levels of NSE and S-
Discussion
Here we demonstrate in healthy young men that a single night of sleep loss increases morning serum concentrations of NSE and S-100B by about ~20 %, relative to values obtained after one night of sleep. These factors are usually found in the cytoplasm of neurons and glia cells [11] [12] [13] [14] .
These findings therefore suggest that a good night's sleep may possess neuroprotective function in humans, as has also been suggested by others 15, 16 .
During a normal sleep-wake cycle, sleep represents a period during which brain glucose metabolism drops by ~30%, compared with values obtained during wakefulness 17 . One reason for this sleep-related drop in central nervous system energy expenditure might be that the thalamic relay of environmental information to sensory cortical areas is dampened 18 . In contrast, during nocturnal wakefulness, this relay of sensory information is nearly as high as it is during daytime 18 . Substrate oxidation ultimately leads to the production of reactive oxygen species (ROS), such as hydrogen peroxide 19 . Previous experiments have demonstrated that ROS can damage neurons and even induce cell death 20 . With this in mind, the increase in morning serum concentrations of NSE and S-100B observed after a single night of sleep loss in our participants might be caused by an increased nocturnal ROS production in the brain.
Recently, it has been demonstrated that acute sleep deprivation increases CSF concentrations of When interpreting our results, several limitations should be kept in mind. Lights were on in the TSD condition but not in the sleep condition (~300 lux versus darkness). Thus, it cannot be ruled out that light exposure may have contributed to the sleep-deprivation-induced increase in serum levels of S-100B and NSE. Another limitation is that the increase in serum concentrations of NSE and S-100B in the morning after sleep loss might be induced by an impaired blood-brain barrier (BBB) function (i.e., as a result of leakage from the CSF) 21 , rather than a consequence of increased nocturnal neuronal damage. To test this hypothesis, future studies could measure betatrace protein, which is highly enriched in the CNS and CSF, and has been proposed as biomarker to diagnose CSF leakage after trauma or surgery 22 . Alternatively, both serum and CSF could be sampled after sleep loss. This would allow elucidating if the increase in serum NSE and S-100B is primarily caused by neuronal damage, impaired blood-brain barrier function, or is just a consequence of increased gene expression in non-neuronal cells, such as leukocytes 23 . Such CSF measures would also help to draw definite conclusions peptide metabolism.
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